Drug · DIN 02422883
INLYTA
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since March 31, 2025.
- Drug Identification Number (DIN)
- 02422883
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Axitinib L01EK01
- Class
- Human
- Record last updated
- April 4, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AXITINIB | 3 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 24, 2014: NOC 15441Supplement to a New Drug Submission (SNDS) · New strengths - 3.0 mg and 7.0 mg
Other DINs named INLYTA
- DIN 02389630 · Marketed
- DIN 02389649 · Marketed
- DIN 02422891 · Cancelled Pre Market